Alnylam Pharmaceuticals (ALNY)'s 30-day implied volatility (IV30) was 53.3% at the close on November 6, 2026, down from 60.4% the day before, against a 52-week range of 35.6% to 63.2%. Its 20-day historical volatility was 44.5%.
Data as of November 6, 2026.